Cohen & Steers Inc (CNS)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NYSE
Market Cap: $3.67B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cohen & Steers Inc (CNS) Stock Forecast
Analysts expect Cohen & Steers (CNS) to earn $3.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $608.47M. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 3.33, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 33% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 33.3% |
| Hold | 1 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 33.3% |
- Consensus
- Hold
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 7.2% and revenue estimates rise 5.9%.
- Fiscal year ending Dec 31, 2026
- $3.46
- EPS consensus, revenue $608.47M
- Fiscal year ending Dec 31, 2027
- $3.71
- EPS consensus, revenue $644.59M
- Next report
- Jan 20, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.46 | $3.34 to $3.63 | 3 | $608.47M | $604.40M to $612.54M | 2 |
| Dec 31, 2027 | $3.71 | $3.32 to $4.04 | 3 | $644.59M | $625.00M to $664.18M | 2 |
Quarterly Estimates
The EPS consensus falls from $0.86 for the quarter ending Dec 31, 2026 to $0.80 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.86 | $0.79 to $0.93 | 3 | $153.33M | $148.77M to $159.40M | 2 |
| Mar 31, 2027 | $0.80 | $0.80 to $0.80 | 1 | $153.66M | $151.53M to $155.79M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 4 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 0.9% from $3.49.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $3.46 | $3.52 | $3.53 | $3.53 | $3.49 | -0.8% |
| Fiscal year ending Dec 31, 2027 | $3.71 | $3.74 | $3.98 | $3.98 | $3.89 | -4.7% |
| Quarter ending Mar 31, 2027 | $0.80 | $0.80 | $0.89 | $0.95 | $0.93 | -13.5% |
Frequently Asked Questions About CNS
What is the CNS stock forecast?
Consensus analyst estimates put Cohen & Steers's EPS at $3.46 for the fiscal year ending Dec 31, 2026, on revenue of $608.47M. The consensus rating from 3 analysts is Hold.
How do analysts rate CNS stock?
Of 3 analysts covering Cohen & Steers, 0 rate it Strong Buy, 1 Buy, 1 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CNS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $3.46, with estimates from $3.34 to $3.63 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.71, with estimates from $3.32 to $4.04 from 3 analysts.
What revenue do analysts expect from Cohen & Steers next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $608.47M, with estimates from $604.40M to $612.54M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $644.59M, with estimates from $625.00M to $664.18M.
How many analysts cover CNS?
3 analysts rate Cohen & Steers stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CNS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors